Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.50 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | MMP12 | P39900 | 3/20 | 0.36 |
| ▸ | MMP13 | P45452 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 1/20 | 0.30 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
| ▸ | MMP14 | P50281 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17204383 | 1.00 | SLC22A6 (0.50) | SLC22A6GABRR1LMNAMAPTMMP12 | |
| SCHEMBL6951133 | 1.00 | SLC22A6 (0.50) | SLC22A6GABRR1LMNAMAPTMMP12 | |
| SCHEMBL17203945 | 1.00 | SLC22A6 (0.50) | SLC22A6GABRR1LMNAMAPTMMP12 | |
| SCHEMBL1135904 | 1.00 | SLC22A6 (0.50) | SLC22A6GABRR1LMNAMAPTMMP12 | |
| SCHEMBL197015 | 0.89 | — | — | |
| SCHEMBL198166 | 0.89 | — | — | |
| SCHEMBL197016 | 0.89 | — | — | |
| SCHEMBL6928974 | 0.86 | SLC22A6 (0.55) | SLC22A6GABRR1LMNAMAPTMMP12 | |
| SCHEMBL6928104 | 0.86 | SLC22A6 (0.55) | SLC22A6GABRR1LMNAMAPTMMP12 | |
| SCHEMBL6928106 | 0.86 | SLC22A6 (0.55) | SLC22A6GABRR1LMNAMAPTMMP12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1054860-B1 | PROCESS FOR THE SYNTHESIS OF 1,3-DIOLS | PFIZER IRELAND PHARMACEUTICALS (IE) | 2007-04-25 | — | — | EP | claimed |
| EP-1480943-A2 | SYNTHESIS OF 3,5-DIHYDROXY-7-PYRROL-1-YL HEPTANOIC ACIDS | Teva Pharmaceutical Industries Limited (IL) | 2004-12-01 | — | — | EP | claimed |
| WO-2004046105-A2 | SYNTHESIS OF 3,5-DIHYDROXY-7-PYRROL-1-YL HEPTANOIC ACIDS | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2004-06-03 | — | — | WO | claimed |
| EP-1077212-B1 | PROCESS FOR PRODUCING 6-CYANOMETHYL-1,3-DIOXANE-4-ACETIC ACID DERIVATIVES | KANEKA CORP (JP) | 2003-08-20 | — | — | EP | claimed |
| US-6344569-B1 | MULTISTAGE REACTION, CYANATION AND ACETALIZATION IN THE PRESENCE OF ACID CATALYST | KANEKA CORPORATION (JP) | 2002-02-05 | — | — | US | claimed |
| EP-1077212-A1 | PROCESS FOR PRODUCING 6-CYANOMETHYL-1,3-DIOXANE-4-ACETIC ACID DERIVATIVES | KANEKA CORPORATION (JP) | 2001-02-21 | — | — | EP | claimed |
| CN-109295119-B | Biocatalysis method for producing statin drug intermediate | 浙江宏元药业股份有限公司 | 2021-08-06 | — | — | CN | disclosed |
| CN-107653238-B | Carbonyl reductase gene engineering bacterium immobilized cell and application thereof | 浙江工业大学 | 2021-05-11 | — | — | CN | disclosed |
| CN-108048438-B | Halohydrin dehalogenase mutant and application thereof | 浙江宏元药业股份有限公司 | 2020-08-18 | — | — | CN | disclosed |
| CN-105622566-B | A kind of preparation method of bis- substituted hydroxy -6- substitution caproates of 3,5- | 上海弈柯莱生物医药科技有限公司 | 2018-07-27 | — | — | CN | disclosed |
| CN-103145584-A | Method for synthesizing (3R,5R)-3,5-dihydroxy-6-cyanohexanoate | UNIV FUDAN | 2013-06-12 | — | — | CN | disclosed |
| CN-103145584-A | Method for synthesizing (3R,5R)-3,5-dihydroxy-6-cyanohexanoate | UNIV FUDAN | 2013-06-12 | — | — | CN | disclosed |
| WO-2008075165-A1 | NOVEL PROCESS FOR THE SYNTHESIS OF [R-(R*, R*)]-2-(4-FLUOROPHENYL)-BETA, DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | PFIZER PRODUCTS INC. (US) | 2008-06-26 | — | — | WO | disclosed |
| WO-2008059366-A2 | PROCESS FOR THE PREPARATION OF CIS-1, 3-DIOLS FROM THE CORRESPONDING BETA-HYDROXY KETONES EMPLOYING MICROBIAL KETONE REDUCTASES | PFIZER PRODUCTS INC. (US) | 2008-05-22 | — | — | WO | disclosed |
| WO-2007137816-A1 | PROCESS FOR THE PREPARATION OF EPOXIDE INTERMEDIATES FOR PHARMACEUTICAL COMPOUNDS SUCH AS STATINS | DSM IP ASSETS B.V. (NL) | 2007-12-06 | — | — | WO | disclosed |
| WO-2006131933-A1 | ENZYMATIC REDUCTION OF KETO GROUPS IN 3-KETO-PROPIONIC ACID DERIVATIVES | BIOCON LIMITED (IN) | 2006-12-14 | — | — | WO | disclosed |
| EP-1077212-B1 | PROCESS FOR PRODUCING 6-CYANOMETHYL-1,3-DIOXANE-4-ACETIC ACID DERIVATIVES | KANEKA CORP (JP) | 2003-08-20 | — | — | EP | disclosed |
| US-6344569-B1 | MULTISTAGE REACTION, CYANATION AND ACETALIZATION IN THE PRESENCE OF ACID CATALYST | KANEKA CORPORATION (JP) | 2002-02-05 | — | — | US | disclosed |
| EP-1077212-A1 | PROCESS FOR PRODUCING 6-CYANOMETHYL-1,3-DIOXANE-4-ACETIC ACID DERIVATIVES | KANEKA CORPORATION (JP) | 2001-02-21 | — | — | EP | disclosed |